Alomari, G., AL-Trad, B., Qar, J., Tahat, L., Haija, Y. A., Al-najjar, A., Albokhadaim, I., Shousha, S., Alameen, A. O., Shukry, M. (2026). Myricetin alleviates testosterone-induced benign prostatic hyperplasia by attenuating inflammation, oxidative stress, apoptosis and androgen signaling. Scientific Reports. https://doi.org/10.1038/s41598-026-47374-0